Day: June 10, 2024

INVESTOR NEWS no. 42 – 10 June 2024 DFDS has today entered into an agreement to divest the Oslo-Frederikshavn-Copenhagen (OFC) cruise ferry route to Gotlandsbolaget. Completion of the agreement is expected in October 2024. The OFC route annually carries more than 700,000 passengers between Norway and Denmark. The route deploys two cruise ferries and has just over 800 sea- and land-based employees. Revenue in 2023 was DKK 0.9bn equal to 3% of the DFDS Group’s total revenue. “It is with a heavy heart that we have found a new home for the Oslo route as it has been a part of DFDS since our foundation in 1866 and in addition a cherished public institution in Denmark and Norway. DFDS is however today a transport and logistics company bridging Europe and the route deserves a new owner that can continue to invest in and develop the...

Paris, France – June 10, 2024 Viridien, formerly CGG, today launched its new brand at the 2024 EAGE Annual Conference in Oslo, marking the next stage in its strategic growth as an Advanced Technology, Digital and Earth Data company. Since this strategy was announced in 2018, the company has divested its data acquisition activities and increased the differentiation in its core businesses of Geoscience, Earth Data and Sensing & Monitoring. New Businesses are also positioned for growth in the Low-Carbon markets of Minerals & Mining and Carbon Storage, as well as in markets beyond energy in High-Performance Computing (HPC) and Infrastructure Monitoring. This portfolio uniquely positions Viridien to support clients in efficiently and responsibly solving their complex natural resource, digital, energy transition and infrastructure...

European Commission approves Roche’s Alecensa as the first and only targeted adjuvant treatment for people with ALK-positive early-stage lung cancerAlecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive resected non-small cell lung cancer, as demonstrated in the Phase III ALINA study1 Alecensa’s approval addresses an urgent unmet need in the early-stage setting where about half of all people experience disease recurrence following surgery, despite adjuvant chemotherapy2 Early diagnosis and treatment of lung cancer can reduce the burden associated with progressive disease and give people the best possible chance of cure3-6Basel, 10 June 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission has approved Alecensa® (alectinib) monotherapy, as adjuvant...

The test uses highly sensitive PCR technology, requiring only a single nasal-swab sample to provide rapid, accurate qualitative detection and differentiation among four of the most prevalent respiratory viruses for which differential diagnosis can drive appropriate treatment. Enables healthcare professionals to make confident clinical decisions and promptly determine appropriate treatment, with definitive results reported in just 20 minutes. Expands Roche’s extensive molecular point of care testing portfolio, offering greater flexibility to meet testing needs amid evolving regional prevalence of respiratory infections.Basel, 10 June 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its cobas® liat SARS-CoV-2, Influenza A/B &...

Hepsor SPV I Ltd, a Ontario-based subsidiary of Hepsor AS, made its third investment in the Canadian real estate market. An assembly of 7 properties was acquired in the much desired midtown Toronto neighborhood of Leaside, at 17-29 Glenavy Avenue, together with Canadian partners, Elysium Investments Inc. (Elysium). Elysium Glenavy Limited Partnership was formed to develop the property in which, in addition to Hepsor and Elysium, various Canadian and European investors are also participating. Fasken (www.fasken.com), one of Canada’s largest law firms, served as legal counsel for Hepsor, reviewing the partnership agreements and providing advice on deal structure and risk mitigation. The initial phase of the critical path of the project will involve the activation of a best-in-class consultant team led by the project architects, internationally...

This award recognizes leading third-party logistics and cold storage providers in the cold food and beverage industry CHATTANOOGA, Tenn., June 10, 2024 (GLOBE NEWSWIRE) — Food Logistics named Covenant Logistics Group as one of the winners of this year’s Top 3PL & Cold Storage Providers Award, which recognizes leading 3PLs and cold storage providers in the cold food and beverage industry. “3PLs and cold storage providers remain a key puzzle piece to building and nurturing partnerships, cultivating resilience and helping companies in the cold food space overcome supply chain disruptions,” says Marina Mayer, Editor-in-Chief of Food Logistics and Supply & Demand Chain Executive. “Seventy-six percent of the winners plan to invest in software solutions this year. This is indicative of how forward-thinking these 3PLs and cold...